Physician profile
Paul M Ahn
NPI 1609934298
$15,165.28
in general payments reported to CMS, 2019-2025
45 companies · $1,710 in 2025
The $1,710 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,288 · 2020: $2,214 · 2021: $2,465 · 2022: $1,980 · 2023: $2,195 · 2024: $2,313 · 2025: $1,710.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,217.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $3,790.29 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $2,253.49 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,343.83 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $1,283.94 | 2019-2025 | Ubrelvy, Qulipta |
| Amarin Pharma, INC. | $783.37 | 2019-2023 | |
| Glaxosmithkline, LLC. | $684.15 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $576.79 | 2019-2025 | Jardiance |
| Exact Sciences Corporation | $471.29 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $456.91 | 2022-2023 | |
| Pfizer INC. | $407.05 | 2020-2025 | |
| Amgen INC. | $332.25 | 2019-2023 | Otezla, Repatha |
| Phathom Pharmaceuticals, INC. | $295.00 | 2024-2025 | Voquezna |
| Janssen Pharmaceuticals, INC | $253.34 | 2019-2023 | Xarelto |
| Nestle Healthcare Nutrition INC. | $225.08 | 2020-2023 | |
| Merck Sharp & Dohme LLC | $224.04 | 2019-2025 | Lagevrio |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Ahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.